⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL896223 | 0.93 | — | — | |
| SCHEMBL896243 | 0.85 | — | — | |
| SCHEMBL6908082 | 0.76 | — | — | |
| SCHEMBL9435416 | 0.76 | — | — | |
| SCHEMBL9781386 | 0.74 | — | — | |
| SCHEMBL28186583 | 0.74 | — | — | |
| SCHEMBL863535 | 0.74 | — | — | |
| SCHEMBL22470615 | 0.73 | — | — | |
| SCHEMBL11660583 | 0.73 | — | — | |
| SCHEMBL11660579 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |